Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease

Volume: 17, Issue: 4, Pages: 242 - 257
Published: Jan 17, 2020
Abstract
Advances in antiplatelet therapies for patients with cardiovascular disease have improved patient outcomes over time, but the challenge of balancing the risks of ischaemia and bleeding remains substantial. Moreover, many patients with cardiovascular disease have a residual risk of ischaemic events despite receiving antiplatelet therapy. Therefore, novel strategies are needed to prevent clinical events through mechanisms beyond platelet...
Paper Details
Title
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease
Published Date
Jan 17, 2020
Volume
17
Issue
4
Pages
242 - 257
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.